Prenatal Stem Cell Transplantation and Gene Therapy

Clinics in Perinatology

Volumn 36, Issue 2, 2009, Pages 451-471

  Santore, Matthew T ^a   Roybal, Jessica L ^a   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Fetal therapy; Gene therapy; Hematopoietic stem cell transplantation; Immunologic tolerance; Prenatal treatment

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BUSULFAN; DYSTROPHIN; GENOMIC DNA; LENTIVIRUS VECTOR; NAKED DNA; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; VIRUS VECTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CENTRAL NERVOUS SYSTEM DISEASE; CONGENITAL DISORDER; CYSTIC FIBROSIS; EARLY INTERVENTION; ENGRAFTMENT; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMOPHILIA; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOLOGICAL TOLERANCE; IN UTERO STEM CELL TRANSPLANTATION; LOW DRUG DOSE; MULTIPOTENT STEM CELL; MUSCULAR DYSTROPHY; NONHUMAN; NONVIRAL GENE THERAPY; PATIENT SAFETY; PLURIPOTENT STEM CELL; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; TOTIPOTENT STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

FEMALE; FETAL DISEASES; GENE THERAPY; HUMANS; PREGNANCY; PRENATAL CARE; STEM CELL TRANSPLANTATION;

EID: 67649093971     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2009.03.006     Document Type: Review

References (123)

1. Weissman I.L., and Shizuru J.A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112 (2008) 3543-3553
2. Kamm F.M. Ethical issues in using and not using embryonic stem cells. Stem Cell Rev 1 (2005) 325-330
3. Flake A.W., and Zanjani E.D. In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers. Blood 94 (1999) 2179-2191
4. Billingham R., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603-607
5. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6 (2006) 127-135
6. Palmer E. Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol 3 (2003) 383-391
7. Ashizuka S., Peranteau W.H., Hayashi S., et al. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 34 (2006) 359-368
8. Hayashi S., Peranteau W.H., Shaaban A.F., et al. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 100 (2002) 804-812
9. Peranteau W.F., Hayashi S., Hsieh M., et al. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 100 (2002) 2225-2234
10. Anderson D., Billingham R., Lampkin G., et al. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5 (1951) 379-397
11. Cragle R., and Stone W. Preliminary results of kidney grafts between cattle chimeric twins. Transplantation 5 (1967) 328-335
12. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science 102 (1945) 400-401
13. Gill T. Chimerism in humans. Transplant Proc 9 (1977) 1423-1431
14. Hansen H.E., Niebuhr E., and Lomas C. Chimeric twins. T.S. and M.R. reexamined. Hum Hered 34 (1984) 127-130
15. Thomsen M., Hansen H.E., and Dickmeiss E. MLC and CML studies in the family of a pair of HLA haploidentical chimeric twins. Scand J Immunol 6 (1977) 523-528
16. Picus J., Aldrich W.R., and Letvin N.L. A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system. Transplantation 39 (1985) 297-303
17. Picus J., Holley K., Aldrich W.R., et al. A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions. J Exp Med 162 (1985) 2035-2052
18. Christensen J.L., Wright D.E., Wagers A.J., et al. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol 2 (2004) 0368-0377
19. Medvinsky A., and Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86 (1996) 897-906
20. Harrison D.E., Zhong R.K., Jordan C.T., et al. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol 25 (1997) 293-297
21. Rebel V.I., Miller C.L., Eaves C.J., et al. The repopulating potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 87 (1996) 3500-3507
22. Shaaban A.F., Kim H.B., Milner R., et al. A kinetic model for homing and migration of prenatally transplanted marrow. Blood 94 (1999) 3251-3257
23. Peranteau W.H., Endo M., Adibe O.O., et al. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 108 (2006) 4268-4274
24. Fleischman R., and Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic cells into the fetal placenta. Proc Natl Acad Sci U S A 76 (1979) 5736-5740
25. Mintz B., Anthony K., and Litwin S. Monoclonal derivation of mouse myeloid and lymphoid lineages from totipotent hematopoietic stem cells experimentally engrafted in fetal hosts. Proc Natl Acad Sci U S A 81 (1984) 7835-7839
26. Blazar B.R., Taylor P.A., and Vallera D.A. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 85 (1995) 833-841
27. Blazar B.R., Taylor P.A., and Vallera D.A. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood 86 (1995) 4353-4366
28. Waldschmidt T.J., Panoskaltsis-Mortari A., McElmurry R.T., et al. Abnormal T cell-dependent B-cell responses in SCID mice receiving allogeneic bone marrow in utero. Severe combined immune deficiency. Blood 100 (2002) 4557-4564
29. Lovell K.L., Kraemer S.A., Leipprandt J.R., et al. In utero hematopoietic stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases. Fetal Diagn Ther 16 (2001) 13-17
30. Pearce R., Kiehm D., Armstrong D., et al. Induction of hematopoietic chimerism in the caprine fetus by intraperitoneal injection of fetal liver cells. Experientia 45 (1989) 307-308
31. Blakemore K., Hattenburg C., Stetten G., et al. In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am J Obstet Gynecol 190 (2004) 960-973
32. Omori F., Lutzko C., Abrams-Ogg A., et al. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses. Exp Hematol 27 (1999) 242-249
33. Harrison M.R., Slotnick R.N., Crombleholme T.M., et al. In utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 2 (1989) 1425-1427
34. Shields L.E., Gaur L., Delio P., et al. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates. J Med Primatol 34 (2005) 201-208
35. Shields L.E., Gaur L.K., Gough M., et al. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 21 (2003) 304-313
36. Cowan M.J., Tarantal A.F., Capper J., et al. Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys. Bone Marrow Transplant 17 (1996) 1157-1165
37. Carrier E., Gilpin E., Lee T.H., et al. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity. J Lab Clin Med 136 (2000) 224-235
38. Carrier E., Lee T.H., Busch M.P., et al. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 86 (1995) 4681-4690
39. Howson-Jan K., Matloub Y.H., Vallera D.A., et al. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation 56 (1993) 709-716
40. Kim H.B., Shaaban A.F., Yang E.Y., et al. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 77 (1998) 1-5
41. Flake A.W., Harrison M.R., Adzick N.S., et al. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 233 (1986) 776-778
42. Srour E.F., Zanjani E.D., Brandt J.E., et al. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79 (1992) 1404-1412
43. Zanjani E.D., Flake A.W., Rice H., et al. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 93 (1994) 1051-1055
44. Zanjani E.D., Pallavicini M.G., Flake A.W., et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89 (1992) 1178-1188
45. Narayan A.D., Chase J.L., Lewis R.L., et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 107 (2006) 2180-2183
46. Kim H.B., Shaaban A.F., Milner R., et al. In utero bone marrow transplantation induces tolerance by a combination of clonal deletion and anergy. J Pediatr Surg 34 (1999) 726-730
47. Pallavicini M.G., Flake A.W., Madden D., et al. Hemopoietic chimerism in rodents transplanted in utero with fetal human hemopoietic cells. Transplant Proc 24 (1992) 542-543
48. Hayashi S., Abdulmalik O., Peranteau W.H., et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol 31 (2003) 176-184
49. Hayashi S., Hsieh M., Peranteau W.H., et al. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol 32 (2004) 290-299
50. Merianos D.J., Tiblad E., Laje P., et al. Breast milk transmission of maternal alloantibodies activates a prenatal immune response that limits allogeneic engraftment after in utero hematopoietic stem cell transplantation in the murine model. Blood 112 11 (2008) 362a
51. Waddington S.N., Mitrophanous K.A., Ellard F.M., et al. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. Gene Ther 10 (2003) 1234-1240
52. Javazon E.H., Merchant A.M., Danzer E., et al. Reconstitution of hematopoiesis following intrauterine transplantation of stem cells. Methods Mol Med 105 (2005) 81-94
53. Peranteau W.H., Endo M., Adibe O.O., et al. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 109 (2007) 1331-1333
54. Merianos D., Heaton T., and Flake A.W. In utero hematopoietic stem cell transplantation: progress toward clinical application. Biol Blood Marrow Transplant 14 (2008) 729-740
55. Durkin E.T., Jones K.A., Rajesh D., et al. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood 112 (2008) 5245-5253
56. Lee P.W., Cina R.A., Randolph M.A., et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol 33 (2005) 371-379
57. Lee P.W., Cina R.A., Randolph M.A., et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine. Transplantation 79 (2005) 1084-1090
58. Storb R., Deeg H.J., Raff R., et al. Prevention of graft-versus-host disease. Studies in a canine model. Ann N Y Acad Sci 770 (1995) 149-164
59. Storb R., and Thomas E.D. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 88 (1985) 215-238
60. Peranteau W.H., Heaton T.E., Gu Y.-C., et al. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same donor transplants in the canine leukocyte adhesion deficiency model. Biology of Blood and Bone Marrow Transplantation 15 (2009) 293-305
61. Flake A., Roncarolo M.-G., Puck J., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335 (1996) 1806-1810
62. Touraine J.L., Raudrant D., and Laplace S. Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally. Transplant Proc 29 (1997) 712-713
63. Wengler G., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet 348 (1996) 1484-1487
64. Westgren M., Ringden O., Bartmann P., et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 187 (2002) 475-482
65. Endoh M., Koibuchi N., Sato M., et al. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 5 (2002) 501-508
66. Sato M., Tanigawa M., and Kikuchi N. Nonviral gene transfer to surface skin of mid-gestational murine embryos by intraamniotic injection and subsequent electroporation. Mol Reprod Dev 69 (2004) 268-277
67. Yoshizawa J., Li X.K., Fujino M., et al. Successful in utero gene transfer using a gene gun in midgestational mouse fetuses. J Pediatr Surg 39 (2004) 81-84
68. Gubbels S.P., Woessner D.W., Mitchell J.C., et al. Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 455 (2008) 537-541
69. David A., Cook T., Waddington S., et al. Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the beta-galactosidase and human factor IX genes to early gestation fetal sheep in utero. Hum Gene Ther 14 (2003) 353-364
70. Sylvester K.G., Yang E.Y., Cass D.L., et al. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 32 (1997) 964-969
71. Yang E.Y., Cass D.L., Sylvester K.G., et al. BAPS Prize-1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British association of paediatric surgeons. J Pediatr Surg 34 (1999) 235-241
72. Iwamoto H.S., Trapnell B.C., McConnell C.J., et al. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther 6 (1999) 98-106
73. Gonzaga S., Henriques-Coelho T., Davey M., et al. Cystic adenomatoid malformations are induced by localized FGF10 overexpression in fetal rat lung. Am J Respir Cell Mol Biol 39 (2008) 346-355
74. Mueller C., and Flotte T.R. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15 (2008) 858-863
75. Olsen J.C. Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 5 (1998) 1481-1487
76. Zufferey R., Nagy D., Mandel R.J., et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15 (1997) 871-875
77. Sena-Esteves M., Tebbets J.C., Steffens S., et al. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122 (2004) 131-139
78. Steffens S., Tebbets J., Kramm C.M., et al. Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes. J Neurooncol 70 (2004) 281-288
79. Findlater G.S., McDougall R.D., and Kaufman M.H. Eyelid development, fusion and subsequent reopening in the mouse. J Anat 183 Pt 1 (1993) 121-129
80. Kaufman M.H., and Bard J. The anatomical basis of mouse development (1999), Academic Press, San Diego (CA)
81. Baker C.V., and Bronner-Fraser M. Vertebrate cranial placodes I. Embryonic induction. Dev Biol 232 (2001) 1-61
82. Blackburn C.C., and Manley N.R. Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 4 (2004) 278-289
83. Graw J. The genetic and molecular basis of congenital eye defects. Nat Rev Genet 4 (2003) 876-888
84. Pispa J., and Thesleff I. Mechanisms of ectodermal organogenesis. Dev Biol 262 (2003) 195-205
85. Hardman M.J., Sisi P., Banbury D.N., et al. Patterned acquisition of skin barrier function during development. Development 125 (1998) 1541-1552
86. M'Boneko V., and Merker H.J. Development and morphology of the periderm of mouse embryos (days 9-12 of gestation). Acta Anat (Basel) 133 (1988) 325-336
87. Byrne C., Hardman M., and Nield K. Covering the limb-formation of the integument. J Anat 202 (2003) 113-123
88. Kaufman M.H. The atlas of mouse development (1992), Academic Press, San Diego (CA)
89. Buckley S.M., Waddington S.N., Jezzard S., et al. Factors influencing adenovirus-mediated airway transduction in fetal mice. Mol Ther 12 (2005) 484-492
90. Holzinger A., Trapnell B.C., Weaver T.E., et al. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 38 (1995) 844-850
91. Endo M., Zoltick P.W., Peranteau W.H., et al. Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 16 (2008) 131-137
92. Endo M., Zoltick P.W., Chung D.C., et al. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 15 (2007) 579-587
93. Hasbrouck N.C., and High K.A. AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects. Gene Ther 15 (2008) 870-875
94. Zaiss A.K., and Muruve D.A. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Ther 15 (2008) 808-816
95. Lipshutz G.S., Sarkar R., Flebbe-Rehwaldt L., et al. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci U S A 96 (1999) 13324-13329
96. Schneider H., Muhle C., Marie Douar A., et al. Sustained delivery of therapeutic concentrations of human clotting factor IX-a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 4 (2002) 46-53
97. Waddington S.N., Nivsarkar M.S., Mistry A.R., et al. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104 (2004) 2714-2721
98. Sabatino D.E., Mackenzie T.C., Peranteau W., et al. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol Ther 15 (2007) 1677-1685
99. Niiya M., Endo M., Shang D., et al. Correction of ADAMTS13 Deficiency by in Utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther 17 (2009) 34-41
100. Bouchard S., MacKenzie T.C., Radu A.P., et al. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J Gene Med 5 (2003) 941-950
101. Mackenzie T.C., Kobinger G.P., Kootstra N.A., et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 6 (2002) 349-358
102. MacKenzie T.C., Kobinger G.P., Louboutin J.P., et al. Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors. J Gene Med 7 (2005) 50-58
103. Weisz B., David A.L., Gregory L.G., et al. Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy. Am J Obstet Gynecol 193 (2005) 1105-1109
104. Gregory L.G., Waddington S.N., Holder M.V., et al. Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy. Gene Ther 11 (2004) 1117-1125
105. Reay D.P., Bilbao R., Koppanati B.M., et al. Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 15 (2008) 531-536
106. Westlake V.J., Jolly R.D., Jones B.R., et al. Hematopoietic cell transplantation in fetal lambs with ceroid-lipofuscinosis. Am J Med Genet 57 (1995) 365-368
107. Karolewski B.A., and Wolfe J.H. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII. Mol Ther 14 (2006) 14-24
108. Larson J.E., Morrow S.L., Happel L., et al. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 349 (1997) 619-620
109. Buckley S.M., Waddington S.N., Jezzard S., et al. Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice. Mol Ther 16 (2008) 819-824
110. Davies L.A., Varathalingam A., Painter H., et al. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol Ther 16 (2008) 812-818
111. David A.L., Weisz B., Gregory L., et al. Ultrasound-guided injection and occlusion of the trachea in fetal sheep. Ultrasound Obstet Gynecol 28 (2006) 82-88
112. Luton D., Oudrhiri N., de Lagausie P., et al. Gene transfection into fetal sheep airways in utero using guanidinium-cholesterol cationic lipids. J Gene Med 6 (2004) 328
113. Henriques-Coelho T., Gonzaga S., Endo M., et al. Targeted Gene Transfer to Fetal Rat Lung Interstitium by Ultrasound-guided Intrapulmonary Injection. Mol Ther 15 (2007) 340-347
114. Tarantal A.F., McDonald R.J., Jimenez D.F., et al. Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery. Mol Ther 12 (2005) 87-98
115. Prenatal gene tranfer. scientific, medical, and ethical issues: a report of the recombinant DNA advisory committee. Hum Gene Ther 11 (2000) 1211-1229
116. Hacein-Bey-Abina S., Garrigue A., Wang G.P., et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118 (2008) 3132-3142
117. Uren A.G., Kool J., Berns A., et al. Retroviral insertional mutagenesis: past, present and future. Oncogene 24 (2005) 7656-7672
118. Themis M., Waddington S.N., Schmidt M., et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12 (2005) 763-771
119. David A.L., and Peebles D. Gene therapy for the fetus: is there a future?. Best Pract Res Clin Obstet Gynaecol 22 (2008) 203-218
120. Tran N.D., Porada C.D., Zhao Y., et al. In utero transfer and expression of exogenous genes in sheep. Exp Hematol 28 (2000) 17-30
121. Lee C.C., Jimenez D.F., Kohn D.B., et al. Fetal gene transfer using lentiviral vectors and the potential for germ cell transduction in rhesus monkeys (Macaca mulatta). Hum Gene Ther 16 (2005) 417-425
122. Porada C.D., Park P.J., Tellez J., et al. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther 12 (2005) 754-762
123. Park P.J., Colletti E., Ozturk F., et al. Factors determining the risk of inadvertent retroviral transduction of male germ cells following in Utero gene transfer in sheep. Hum Gene Ther 20 (2009) 201-215